OHSU Knight Cancer Institute: Pancreatic Neoplasms trials

The registry lists 13 Pancreatic Neoplasms studies with OHSU Knight Cancer Institute as lead sponsor. 4 are open to participants now and 3 have results posted.

Early Phase 1 3Phase 1 2Phase 2 5No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant ChemotherapyRecruitingNCT07651358Not applicable
• OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal AdenocarcinomaRecruitingNCT07089940Early Phase 1
• Use Of Indocyanine Green In Pancreas SurgeryRecruitingNCT06084013
• Targeted Pathway Inhibition in Patients With Pancreatic CancerRecruitingNCT04005690Early Phase 1
• A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic CancerTerminatedNCT06630325Phase 2Results posted
• Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal PancreatectomyTerminatedNCT04965311Phase 2Results posted
• Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryCompletedNCT02427841Phase 2Results posted
• Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal AdenocarcinomaWithdrawnNCT06398587Phase 2
• SMMART Adaptive Clinical Treatment (ACT) TrialWithdrawnNCT05238831Early Phase 1
• Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic CancerCompletedNCT05034627Phase 1
• Monitoring Heart Rate Variability for the Early Detection of Pancreatic CancerTerminatedNCT04400903
• Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
• Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic CancerCompletedNCT00238199Phase 2